Evidence map›Paper›PMID 25232103›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2014

Central vagal afferent endings mediate reduction of food intake by melanocortin-3/4 receptor agonist.

Carlos A Campos, Hiroko Shiina, Robert C Ritter

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Modulatory function of NMDA glutamate receptor on MCVeterinary research communications · 2017
    Article
  10. BioMed research international · 2017
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. NMDA-type glutamate receptors participate in reduction of food intake following hindbrain melanocortin receptor activation.American journal of physiology. Regulatory, integrative and comparative physiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Carlos A CamposDepartment of Integrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, Washington 99164 carloscampos@vetmed.wsu.edu.
Hiroko ShiinaDepartment of Integrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, Washington 99164.
Robert C RitterDepartment of Integrative Physiology and Neuroscience, College of Veterinary Medicine, Washington State University, Pullman, Washington 99164.
Washington State University · US

Funding

The Role of Glutamate in the Control of Food IntakeR01DK052849 · NIDDK · WASHINGTON STATE UNIVERSITY · PI APPLEYARD, SUZANNE M, RITTER, ROBERT C · 1998 to 2021
$6.3M
NEURAL SUBSTRATES OF PEPTIDE-INDUCED SATIETYR01NS020561 · NINDS · WASHINGTON STATE UNIVERSITY · PI RITTER, ROBERT C · 1985 to 2012
$3.6M
NIDDK NIH HHS DK-52849NIDDK NIH HHS R01 DK052849NINDS NIH HHS NS-20561NINDS NIH HHS R01 NS020561
6 · The paper itself

Abstract

Injection of the melanocortin-3/4 receptor agonist melanotan-II (MTII) into the nucleus of the solitary tract (NTS) produces rapid and sustained reduction of food intake. Melanocortin-4 receptors (MC4Rs) are expressed by vagal afferent endings in the NTS, but it is not known whether these endings participate in MTII-induced reduction of food intake. In experiments described here, we evaluated the contribution of central vagal afferent endings in MTII-induced reduction of food intake. Examination of rat hindbrain sections revealed that neuronal processes expressing immunoreactivity for the endogenous MC4R agonist α-melanoctyte-stimulating hormone course parallel and wrap around anterogradely labeled vagal afferent endings in the NTS and thus are aptly positioned to activate vagal afferent MC4Rs. Furthermore, MTII and endogenous MC4R agonists increased protein kinase A (PKA)-catalyzed phosphorylation of synapsin I in vagal afferent endings, an effect known to increase synaptic strength by enhancing neurotransmitter release in other neural systems. Hindbrain injection of a PKA inhibitor, KT5720, significantly attenuated MTII-induced reduction of food intake and the increase in synapsin I phosphorylation. Finally, unilateral nodose ganglion removal, resulting in degeneration of vagal afferent endings in the ipsilateral NTS, abolished MTII-induced synapsin I phosphorylation ipsilateral to nodose ganglion removal. Moreover, reduction of food intake following MTII injection into the NTS ipsilateral to nodose ganglion removal was significantly attenuated, whereas the response to MTII was not diminished when injected into the contralateral NTS. Altogether, our results suggest that reduction of food intake following hindbrain MC4R activation is mediated by central vagal afferent endings.

Indexed as

alpha-MSHAnimalsCarbazolesEatingMaleMicroinjectionsNerve EndingsNeurons, AfferentNodose GanglionPeptides, CyclicPhosphorylationProtein Kinase InhibitorsPyrrolesRatsReceptor, Melanocortin, Type 4Solitary Nucleusalpha-MSHCarbazolesKT 5720melanotan-IIPeptides, CyclicProtein Kinase InhibitorsPyrrolesReceptor, Melanocortin, Type 4Synapsinsgastrointestinalhindbrainsatiation

Identifiers

PMID25232103
PMCPMC4166153
OpenAlexW2049070864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.